Tag Archives: Vanderbilt University

Researchers find novel lncRNA mechanism of resistance to anti-cancer drugs

lncrna

The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors with genetic mutations that make them resistant to these anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, or the cancers develop resistance during treatment. Researchers seeking to understand mechanisms of ...

Read More »

A blood test for multiple sclerosis? Expect one in late May

lncRNA

MedCityNews – The medical toolbox for treating multiple sclerosis (MS) has progressed in leaps and bounds over the last two decades, as highlighted by the recent approval of Ocrevus for the most severe and treatment-resistant form of the disease. Despite this success, the underlying disease mechanisms and triggers are not well understood. This makes diagnosis a challenge — with very high ...

Read More »